湖北荊州、黃岡無新增本土病例 疫情已基本穩定
格隆匯8月7日丨今天,湖北省疫情防控指揮部召開新聞發佈會,通報全省流調工作核武漢市核酸檢測情況。據通報,荊門市中心城區全員核酸檢測已完成採樣59.9萬人。鄂州市、鹹寧市崇陽縣已開始全員核酸檢測,其中,截至8月7日上午12時,鄂州市已完成採樣30萬人,檢測10萬人,結果均爲陰性;截至8月6日24時,鹹寧市崇陽縣核酸檢測已完成採樣8萬人,檢測5.3萬人,結果均爲陰性。荊州市城區已完成一輪核酸檢測,檢測93.3萬人,結果均爲陰性,已連續6天無新增感染者。黃岡市紅安縣已檢測17.5萬人,結果均爲陰性,已連續5天無新增感染者。荊州、黃岡沒有新增本土病例,疫情已基本穩定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.